Neoadjuvant Treatment in Locally Advanced Thyroid Carcinoma

Area of Science:

• Oncology
• Endocrinology
• Surgical Oncology

Background:

• Focus has shifted from overdiagnosis of early-stage thyroid cancer to managing locally advanced tumors.
• Locally advanced thyroid cancers are infrequent but complex, often associated with poor prognoses.
• Traditional treatments involved aggressive surgery or palliative care due to limited preoperative options.

Purpose of the Study:

• To review current scientific evidence on neoadjuvant treatment for locally advanced thyroid cancer.
• To explore the emerging role of neoadjuvant therapy in improving surgical outcomes.
• To discuss the impact of new therapeutic strategies on managing complex thyroid malignancies.

Main Methods:

• Narrative review of existing scientific literature.
• Analysis of studies focusing on neoadjuvant therapies for advanced thyroid cancer.
• Synthesis of evidence on tyrosine kinase inhibitors and tumor biology.

Main Results:

• Neoadjuvant therapy is emerging as a viable curative-intent strategy.
• Tyrosine kinase inhibitors show promise, particularly in radioactive iodine-refractory cases.
• Improved understanding of tumor biology supports targeted neoadjuvant approaches.

Conclusions:

• Neoadjuvant therapy represents a significant advancement in treating locally advanced thyroid cancer.
• This approach offers potential for tumor reduction, enabling less radical surgery.
• Further research into neoadjuvant strategies is crucial for optimizing patient outcomes.